Blood glucose outcomes of anti-retroviral therapy naïve Ugandan people with HIV with pre-diabetes mellitus initiated on dolutegravir for 48 weeks-Reference-Cited by-同舟云学术

Blood glucose outcomes of anti-retroviral therapy naïve Ugandan people with HIV with pre-diabetes mellitus initiated on dolutegravir for 48 weeks

Published:2024-07-29 Issue:1 Volume:24 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Mulindwa Frank,Schwarz Jean-Marc,Brusselaers Nele,Nabwana Martin,Bollinger Robert,Buzibye Allan,Amutuhaire Willington,Yendewa George,Odongpiny Eva Laker Agnes,Kiguba Ronald,Castelnuovo Barbara

Funder

NIH-Fogarty University of California (UCSF) global health fellowship program

National Institutes of Health, UCSF-Gladstone Center for AIDS Research

Fogarty International Center of the National Institutes of Health, Infectious Diseases Institute ‘HIV and coinfections’

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s12879-024-09655-9.pdf

Reference40 articles.

1. Patel P et al. Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: A systematic review and meta-analysis, AIDS, vol. 32. Lippincott Williams and Wilkins, pp. S5–S20, Jul. 01, 2018, https://doi.org/10.1097/QAD.0000000000001888

2. Unaids. Responding to the challenge of non-communicable diseases, https://doi.org/10.1097/QAD.0000000000001888

3. Achwoka D, et al. Noncommunicable disease burden among HIV patients in care: a national retrospective longitudinal analysis of HIV-treatment outcomes in Kenya, 2003–2013. BMC Public Health. Apr. 2019;19(1). https://doi.org/10.1186/s12889-019-6716-2.

4. Jespersen NA, Axelsen F, Dollerup J, Nørgaard M, Larsen CS. The burden of non-communicable diseases and mortality in people living with HIV (PLHIV) in the pre-, early- and late-HAART era, HIV Med, vol. 22, no. 6, pp. 478–490, Jul. 2021, https://doi.org/10.1111/HIV.13077.

5. Vorkoper S, et al. Building on the HIV chronic care platform to address noncommunicable diseases in sub-saharan Africa: a research agenda. AIDS. Jul. 2018;32:S. https://doi.org/10.1097/QAD.0000000000001898.